Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The effect of nirmatrelvir plus ritonavir on the long-term risk of epilepsy and seizure following COVID-19: A retrospective cohort study including 91,528 patients
Ting-Hui Liu, Jheng‐Yan Wu, Po‐Yu Huang, et al.
Journal of Infection (2023) Vol. 86, Iss. 3, pp. 256-308
Open Access | Times Cited: 24

Showing 24 citing articles:

Efficacy of nirmatrelvir and ritonavir for post‐acute COVID‐19 sequelae beyond 3 months of SARS‐CoV‐2 infection
Min‐Hsiang Chuang, Jheng‐Yan Wu, Tinghui Liu, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 4
Closed Access | Times Cited: 21
Early use of oral antiviral drugs and the risk of post COVID-19 syndrome: A systematic review and network meta-analysis
Juan Jiang, Yantong Li, Qiaoling Jiang, et al.
Journal of Infection (2024) Vol. 89, Iss. 2, pp. 106190-106190
Closed Access | Times Cited: 9
Post-acute hospitalization and mortality of nirmatrelvir plus ritonavir for COVID-19 survivors
Wan‐Hsuan Hsu, Ya‐Wen Tsai, Jheng‐Yan Wu, et al.
Journal of Infection (2023) Vol. 86, Iss. 4, pp. e107-e110
Open Access | Times Cited: 17
Clinical efficacy of nirmatrelvir and ritonavir combination for treating diabetic patients with COVID‐19
Jheng‐Yan Wu, Mei‐Yuan Liu, Tinghui Liu, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 6
Open Access | Times Cited: 17
Clinical effectiveness of nirmatrelvir plus ritonavir on the short‐ and long‐term outcome in high‐risk children with COVID‐19
Jheng‐Yan Wu, Chia‐Chen Chen, Mei‐Yuan Liu, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 5
Closed Access | Times Cited: 4
Clinical effectiveness of nirmatrelvir plus ritonavir in patients with COVID‐19 and substance use disorders based on real‐world data
Tinghui Liu, Po‐Yu Huang, Jheng‐Yan Wu, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 5
Closed Access | Times Cited: 11
Effectiveness of oral antiviral agents on long‐term cardiovascular risk in nonhospitalized patients with COVID‐19: A multicenter matched cohort study
Tinghui Liu, Min‐Hsiang Chuang, Jheng‐Yan Wu, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 8
Closed Access | Times Cited: 11
Association between nirmatrelvir plus ritonavir and the outcomes of non-hospitalized obese patients with COVID-19
Jheng‐Yan Wu, Mei‐Yuan Liu, Ting-Hui Liu, et al.
International Journal of Antimicrobial Agents (2023) Vol. 62, Iss. 6, pp. 106984-106984
Closed Access | Times Cited: 11
Omega-3 polyunsaturated fatty acids and the psychiatric post-acute sequelae of COVID-19: A one-year retrospective cohort analysis of 33,908 patients
Ting-Hui Liu, Chung‐Han Ho, Daniel Tzu-Li Chen, et al.
Brain Behavior and Immunity (2023) Vol. 114, pp. 453-461
Open Access | Times Cited: 9
The effect of molnupiravir on post-acute outcome of COVID-19 survivors
Wan‐Hsuan Hsu, Bo-Wen Shiau, Ya‐Wen Tsai, et al.
Journal of Infection (2023) Vol. 87, Iss. 4, pp. 339-343
Open Access | Times Cited: 8
Clinical effectiveness of nirmatrelvir plus ritonavir in the treatment of COVID-19 in patients with cirrhosis
Wan‐Hsuan Hsu, Bo-Wen Shiau, Tinghui Liu, et al.
Expert Review of Anti-infective Therapy (2023) Vol. 21, Iss. 10, pp. 1143-1151
Closed Access | Times Cited: 8
The epidemic characteristics of Mycoplasma pneumoniae infection among children in Anhui, China, 2015–2023
Bing Chen, Ling‐yu Gao, Qiu-ju Chu, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 10
Open Access | Times Cited: 2
Immunomodulation in Non-traditional Therapies for Methicillin-resistant Staphylococcus aureus (MRSA) Management
Suthi Subbarayudu, S. Karthick Raja Namasivayam, Jesu Arockiaraj
Current Microbiology (2024) Vol. 81, Iss. 10
Closed Access | Times Cited: 2
The association between corticosteroids and aspergillosis among COVID-19 patients
Yi-Hsin Chang, Ting-Hui Liu, Jheng‐Yan Wu, et al.
Journal of Infection (2023) Vol. 86, Iss. 4, pp. 394-396
Open Access | Times Cited: 7
The effect of nirmatrelvir‐ritonavir on the long‐term risk of neuropsychiatric sequelae following COVID‐19
Tinghui Liu, Jheng‐Yan Wu, Po‐Yu Huang, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 7
Closed Access | Times Cited: 7
Comparison of post-acute sequelae following hospitalization for COVID-19 and influenza
Ting-Hui Liu, Po‐Yu Huang, Jheng‐Yan Wu, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 6
Post-COVID-19 condition risk in patients with intellectual and developmental disabilities: a retrospective cohort study involving 36,308 patients
Ting-Hui Liu, Po‐Yu Huang, Jheng‐Yan Wu, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 6
Association between vitamin D deficiency and post-acute outcomes of SARS-CoV-2 infection
Jheng‐Yan Wu, Mei‐Yuan Liu, Wan‐Hsuan Hsu, et al.
European Journal of Nutrition (2023)
Closed Access | Times Cited: 5
The effectiveness of novel oral antiviral treatment for non-hospitalized high-risk patients with COVID-19 during predominance of omicron XBB subvariants
Chi‐Kuei Hsu, Wan‐Hsuan Hsu, Bo-Wen Shiau, et al.
Expert Review of Anti-infective Therapy (2024), pp. 1-8
Closed Access | Times Cited: 1
Malnutrition and the Post-Acute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Multi-Institutional Population-Based Propensity Score-Matched Analysis
Cheng-Ya Lee, Yung-Chun Liang, Wan‐Hsuan Hsu, et al.
Life (2024) Vol. 14, Iss. 6, pp. 746-746
Open Access | Times Cited: 1
Effectiveness of molnupiravir for treating COVID-19 in patients with psychiatric disorders
Ting-Hui Liu, Hsuan-Yi Liao, Chih‐Cheng Chang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Clinical efficacy of nirmatrelvir plus ritonavir in patients with COVID-19 and preexisting cardiovascular diseases
Ting-Hui Liu, Jheng‐Yan Wu, Po‐Yu Huang, et al.
Expert Review of Anti-infective Therapy (2023) Vol. 22, Iss. 1-3, pp. 121-128
Closed Access | Times Cited: 3
Clinical effectiveness of nirmatrelvir plus ritonavir for patients with COVID-19 and preexisting psychiatric disorders
Ting-Hui Liu, Jheng‐Yan Wu, Po‐Yu Huang, et al.
Expert Review of Anti-infective Therapy (2024) Vol. 22, Iss. 10, pp. 885-893
Closed Access
Further advances in epilepsy
Joanna B. Fawcett, Sarah Davis, Mark Manford
Journal of Neurology (2023) Vol. 270, Iss. 11, pp. 5655-5670
Closed Access | Times Cited: 1
Page 1

Scroll to top